CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | Baynes Roy D. Director | Sale 10b5-1 | −1,800 | $222.90 | $401K | 22,143 |
| 2025-11-20 | Baynes Roy D. Director | Sale 10b5-1 | −1,900 | $223.90 | $425K | 20,243 |
| 2025-11-20 | Baynes Roy D. Director | Sale 10b5-1 | −1,884 | $224.89 | $424K | 18,359 |
| 2025-11-20 | Baynes Roy D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −600 | 0 | ||
| 2025-11-20 | Baynes Roy D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −7,068 | 0 | ||
| 2025-11-20 | Sheena Jonathan Director | Sale 10b5-1 | −10,000 | $225.08 | $2.3M | 222,660 |
| 2025-11-19 | Baynes Roy D. Director | Option exercise 10b5-1 | +5,112 | $40.93 | $209K | 23,471 |
| 2025-11-19 | Baynes Roy D. Director | Sale 10b5-1 | −1,250 | $213.47 | $267K | 22,221 |
| 2025-11-19 | Baynes Roy D. Director | Sale 10b5-1 | −1,727 | $214.79 | $371K | 20,494 |
| 2025-11-19 | Baynes Roy D. Director | Sale 10b5-1 | −2,135 | $216.07 | $461K | 18,359 |
| 2025-11-19 | Baynes Roy D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,112 | 600 | ||
| 2025-11-11 | Sheena Jonathan Director | Sale 10b5-1 | −205 | $206.86 | $42K | 25,827 |
| 2025-11-11 | Sheena Jonathan Director | Sale 10b5-1 | −382 | $207.95 | $79K | 25,445 |
| 2025-11-11 | Sheena Jonathan Director | Sale 10b5-1 | −163 | $209.28 | $34K | 25,282 |
| 2025-11-11 | Sheena Jonathan Director | Sale 10b5-1 | −190 | $206.86 | $39K | 25,842 |
| 2025-11-11 | Sheena Jonathan Director | Sale 10b5-1 | −390 | $207.94 | $81K | 25,452 |
| 2025-11-11 | Sheena Jonathan Director | Sale 10b5-1 | −170 | $209.28 | $36K | 25,282 |
| 2025-11-07 | Sheena Jonathan Director | Sale 10b5-1 | −1,480 | $190.33 | $282K | 234,250 |
| 2025-11-07 | Sheena Jonathan Director | Sale 10b5-1 | −90 | $191.04 | $17K | 234,160 |
| 2025-11-07 | Sheena Jonathan Director | Sale 10b5-1 | −400 | $192.64 | $77K | 233,760 |
Page 33 of 39 · 767 trades